Publications
Archives
BCIQ
Conferences
Free Trial
/
Subscribe
Sign In
English
简体中文
日本語
한국어
more_vert
Biocentury
// BCIQ
Menu
Home
Publications
Publications Home
BioCentury
BC Innovations
BC Extra
BC Week In Review
Current Issues
Archives
Archives Home
Basic Search
Advanced Search
Back Issues
BCIQ
BCIQ Home
Overview
Newsfeed
Companies
Products
Finance
Deals
Conferences
Conferences Home
Newsmakers
Bio€quity Europe
Future Leaders
China Healthcare Summit
Other Industry Events
eLearning
eLearning Home
Videos
White Papers
Follow Us
Newsfeed
Companies
Products
Finance
Deals
Profile Reports
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
1 documents
BC Week In Review
1
Clinical News
1
Clinical Status
1
Read All
00:38
,
Feb 3, 2017
|
BC Week In Review
|
Clinical News
ASN003: Ph I started
Asana began an open-label, U.S. Phase I trial to evaluate ASN003 in about 100 patients. A dose-escalation part will determine the dose for the expansion cohort in the second part, which will enroll patients with...
Read More